Does stimulant treatment lead to substance use disorders?

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 11, 2003, Pages 9-13

  Faraone, Stephen V ^a   Wilens, Timothy ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; COCAINE; DEXAMPHETAMINE; DEXTROAMP; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

AGE; ALCOHOL ABUSE; ATTENTION DEFICIT DISORDER; COCAINE DEPENDENCE; COMORBIDITY; CONFERENCE PAPER; DISEASE SEVERITY; DRUG DEPENDENCE; HUMAN; LONGITUDINAL STUDY; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; FEMALE; HUMANS; MALE; ODDS RATIO; RESEARCH DESIGN; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0141763834     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279:1100-1107
2. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-1086
3. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? a meta-analytic review of the literature. Pediatrics 2003;111:179-185
4. Diller L. Running on Ritalin. New York, NY: Bantam; 1998
5. Breggin P. Talking Back to Ritalin. Monroe, Me: Common Courage Press; 1998
6. Garland EJ. Intranasal abuse of prescribed methylphenidate [letter]. J Am Acad Child Adolesc Psychiatry 1998;37:573-574
7. Jaffe SL. Intranasal abuse of methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 1991;30:773-775
8. Goyer PF, Davis GC, Rapoport JL. Abuse of prescribed stimulant medication by a 13-year-old boy. J Am Acad Child Adolesc Psychiatry 1979;18:170-175
9. Biederman J, Wilens T, Mick E, et al. Pharmacotherapy of attentiondeficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics [serial online]. 1999;104:e20. Available at: http:// www.pediatrics.org/cgi/content/full/104/2/e20. Accessed Jan 20, 2003
10. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998;31:533-544
11. Loney J. Risk of treatment versus nontreatment. Presented at the National Institute of Health Consensus Development Conference on the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. November 16-18, 1998; Bethesda, Md. Available at: http://consensus.nih.gov/cons/ 110/110_abstract.pdf. Accessed March 13, 2003
12. Molina B, Pelham W, Roth J. Stimulant medication and substance use by adolescents with a childhood history of ADHD [poster]. Presented at the biennial meeting of the International Society for Research in Child and Adolescent Psychopathology; June 17-20, 1999; Barcelona, Spain
13. Barkley RA, Fischer M, Smallish L, et al. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/ abuse? a 13-year prospective study. Pediatrics 2003;111:97-109
14. Huss M. ADHD and substance abuse. In: IX Annual European Congress of Psychiatry. Hamburg, Germany; 1999
15. Huss M. The relationship of ADHD and substance abuse. Presented at the International Conference on ADHD; Feb 26-March 1, 2003; Chicago, Ill
16. Wilens T. Attention deficit hyperactivity disorder and substance use disorders: nature of the relationship, subtypes at risk, and treatment issues. In: Jensen PS, Cooper J, eds. Attention Deficit Hyperactivity Disorder: State of the Science Best Practices. Kingston, NJ: Civic Research Institute; 2002:1-24